Manulife (Manufacturers Life Insurance)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $182K | Sell |
|
|||||
|
2025
Q2 | $166K | Buy |
|
|||||
|
2025
Q1 | $117K | Sell |
|
|||||
|
2024
Q4 | $639K | Buy |
|
|||||
|
2024
Q3 | $976K | Sell |
|
|||||
|
2024
Q2 | $769K | Buy |
|
|||||
|
2024
Q1 | $948K | Buy |
|
|||||
|
2023
Q4 | $455K | Sell |
|
|||||
|
2023
Q3 | $952K | Buy |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $1.1M | Buy |
|
|||||
|
2022
Q4 | $965K | Buy |
|
|||||
|
2022
Q3 | $256K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $357K | Sell |
|
|||||
|
2021
Q4 | $480 | Sell |
|
|||||
|
2021
Q3 | $337K | Sell |
|
|||||
|
2021
Q2 | $383K | Buy |
|
|||||
|
2021
Q1 | $466K | Sell |
|
|||||
|
2020
Q4 | $545K | Buy |
|